Teladoc Health Inc. [NYSE: TDOC] price surged by 0.07 percent to reach at $0.13. A sum of 2424545 shares traded at recent session while its average daily volume was at 3.54M shares. Teladoc Health Inc. shares reached a high of $189.2682 and dropped to a low of $182.70 until finishing in the latest session at $188.41.
The one-year TDOC stock forecast points to a potential downside of -8.28. The average equity rating for TDOC stock is currently 2.30, trading closer to a bullish pattern in the stock market.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Guru’s Opinion on Teladoc Health Inc. [TDOC]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for TDOC shares is $174.00 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on TDOC stock is a recommendation set at 2.30. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
KeyBanc Capital Markets have made an estimate for Teladoc Health Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on April 30, 2020. The new note on the price target was released on April 13, 2020, representing the official price target for Teladoc Health Inc. stock.
The Average True Range (ATR) for Teladoc Health Inc. is set at 10.90, with the Price to Sales ratio for TDOC stock in the period of the last 12 months amounting to 23.36. The Price to Book ratio for the last quarter was 13.80, with the Price to Cash per share for the same quarter was set at 6.80. Price to Free Cash Flow for TDOC in the course of the last twelve months was 514.39 with Quick ratio for the last quarter at 6.10.
TDOC Stock Performance Analysis:
Teladoc Health Inc. [TDOC] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 11.60. With this latest performance, TDOC shares gained by 2.27% in over the last four-week period, additionally plugging by 146.90% over the last 6 months – not to mention a rise of 213.91% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for TDOC stock in for the last two-week period is set at 60.67, with the RSI for the last a single of trading hit 67.28, and the three-weeks RSI is set at 58.67 for Teladoc Health Inc. [TDOC]. The present Moving Average for the last 50 days of trading for this stock 172.07, while it was recorded at 179.88 for the last single week of trading, and 112.79 for the last 200 days.
Insight into Teladoc Health Inc. Fundamentals:
Operating Margin for any stock indicates how profitable investing would be, and Teladoc Health Inc. [TDOC] shares currently have an operating margin of -12.12 and a Gross Margin at +59.62. Teladoc Health Inc.’s Net Margin is presently recorded at -17.87.
Return on Total Capital for TDOC is now -4.61, given the latest momentum, and Return on Invested Capital for the company is -6.80. Return on Equity for this stock declined to -9.75, with Return on Assets sitting at -6.36. When it comes to the capital structure of this company, Teladoc Health Inc. [TDOC] has a Total Debt to Total Equity ratio set at 46.40. Additionally, TDOC Total Debt to Total Capital is recorded at 31.69, with Total Debt to Total Assets ending up at 28.13. Long-Term Debt to Equity for the company is recorded at 45.90, with the Long-Term Debt to Total Capital now at 31.35.
Reflecting on the efficiency of the workforce at the company, Teladoc Health Inc. [TDOC] managed to generate an average of -$41,193 per employee. Receivables Turnover for the company is 11.01 with a Total Asset Turnover recorded at a value of 0.36.Teladoc Health Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 6.10 and a Current Ratio set at 6.10.
TDOC Stock EPS
With the latest financial reports released by the company, Teladoc Health Inc. posted -0.41/share EPS, while the average EPS was predicted by analysts to be reported at -0.41/share. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for TDOC. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Teladoc Health Inc. go to 20.00%.
Teladoc Health Inc. [TDOC] Insider Position Details
There are presently around $14,215 million, in the hands of institutional investors. The top three institutional holders of TDOC stocks are: BLACKROCK INC. with ownership of 7,594,901, which is approximately 6.028% of the company’s market cap and around 1.10% of the total institutional ownership; VANGUARD GROUP INC, holding 6,826,048 shares of the stock with an approximate value of $1.29 billion in TDOC stocks shares; and BAILLIE GIFFORD & CO, currently with $1.09 billion in TDOC stock with ownership of nearly 0.729% of the company’s market capitalization.
321 institutional holders increased their position in Teladoc Health Inc. [NYSE:TDOC] by around 8,453,605 shares. Additionally, 249 investors decreased positions by around 21,570,034 shares, while 43 investors held positions by with 45,474,269 shares. The mentioned changes placed institutional holdings at 75,497,908 shares, according to the latest SEC report filing. TDOC stock had 194 new institutional investments in for a total of 2,293,199 shares, while 36 institutional investors sold positions of 951,839 shares during the same period.